Substituted benzimidazole compounds with dual NOS inhibitory activity and muopioid agonist activity

Details for Australian Patent Application No. 2006277684 (hide)

Owner Neuraxon, Inc.

Inventors Renton, Paul; Rakhit, Suman; Andrews, John; Maddaford, Shawn

Agent Spruson & Ferguson

Pub. Number AU-A-2006277684

PCT Pub. Number WO2007/017764

Priority 60/682,043 18.05.05 US

Filing date 18 May 2006

Wipo publication date 15 February 2007

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/4184 (2006.01)

A61K 31/454 (2006.01)

A61K 31/5377 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07D 235/12 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2007/017764 Priority application(s): WO2007/017764

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006277686-Method of manufacturing an optical system

2006277682-Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections